In Vitro Release Testing for Complex Generics: A Bioequivalence Perspective скачать в хорошем качестве

In Vitro Release Testing for Complex Generics: A Bioequivalence Perspective

Yan Wang from the Office of Generic Drugs discusses issues and scientific considerations for the development and validation of an in vitro drug release testing method for supporting bioequivalence. Learn more at https://www.fda.gov/drugs/regulatory-... _______________________________ FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Upcoming Training - https://www.fda.gov/cdersbia SBIA Listserv - https://public.govdelivery.com/accoun... SBIA 2020 Playlist -    • 2020 CDER Small Business and Industry Assi...   SBIA LinkedIn -   / cder-small-business-and-industry-assistance   SBIA Training Resources - https://www.fda.gov/cderbsbialearn Twitter -   / fda_drug_info   Email - CDERSBIA@fda.hhs.gov Phone - (301) 796-6707 I (866) 405-5367